Arzzt 3.5 / 4.5 Small & Large Fragments System

K162507 · Truemed Group, LLC · HRS · Aug 3, 2017 · Orthopedic

Device Facts

• Record ID: K162507
• Device Name: Arzzt 3.5 / 4.5 Small & Large Fragments System
• Applicant: Truemed Group, LLC
• Product Code: HRS · Orthopedic
• Decision Date: Aug 3, 2017
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 888.3030
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Arzzt 3.5/4.5 Small & Large Fragment System is indicated for fixation of fractures, osteotomies, and non-unions of the humerus, radius, ulna, femur, and tibia.

Device Story

Arzzt 3.5/4.5 Small & Large Fragments System consists of metallic bone plates and screws for orthopedic fracture fixation. Plates feature orifices for locking or non-locking screws; screws may be fully or partially threaded, cannulated or solid, and self-tapping. Used by surgeons in clinical settings for internal fixation of long bone fractures. Device provides mechanical stabilization of bone segments to facilitate healing. Performance verified via engineering analyses comparing static bending and torsional yield strengths, and maximum shear stress against predicate devices.

Clinical Evidence

Bench testing only. Engineering analyses were performed comparing static bending and static torsional yield strengths of plates, and maximum shear stress and thread characteristics of screws against the predicate device. Compliance with ASTM F-983-86, ASTM F543-07, ISO 5832-1:2007, and ISO 5832-3:1996 was demonstrated.

Technological Characteristics

Metallic bone fixation system (plates and screws). Materials: Wrought stainless steel (ISO 5832-1:2007) or titanium 6-aluminum 4-vanadium alloy (ISO 5832-3:1996). Design includes locking/non-locking, cannulated/solid, and self-tapping screw options. Mechanical testing per ASTM F543-07. Permanent marking per ASTM F-983-86.

Indications for Use

Indicated for patients requiring fixation of fractures, osteotomies, and non-unions of the humerus, radius, ulna, femur, and tibia.

Regulatory Classification

Identification

Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

• Synthes (USA) 3.5 mm and 4.5 mm Locking Compression Plate (LCP) System with Expanded Indications (K082807)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles a stylized caduceus, with three human profiles facing right, suggesting a focus on people and health.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

August 3, 2017

Truemed Group LLC % Ms. Lara Luzak Senior Regulatory Specialist Registrar Corp. 144 Research Drive Hampton, Virginia 23666

Re: K162507 Trade/Device Name: Arzzt 3.5 / 4.5 Small & Large Fragments System Regulation Number: 21 CFR 888.3030 Regulation Name: Single/Multiple Component Metallic Bone Fixation Appliances and Accessories Regulatory Class: Class II Product Code: HRS, HWC Dated: July 5, 2017 Received: July 6. 2017

Dear Ms. Luzak:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in

{1}------------------------------------------------

the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely,

Mark N. Melkerson -S

Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

## Indications for Use

510(k) Number (if known) K162507

Device Name

Arzzt 3.5 / 4.5 Small & Large Fragments System

Indications for Use (Describe)

The Arzzt 3.5/4.5 Small & Large Fragment Systems is indicated for fixation of fractures, and nonunions of the humerus, radius, ulna, femur, and tibia.

Type of Use (Select one or both, as applicable)

X Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.qov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

Image /page/3/Picture/2 description: The image contains the logo for TrueMed Group. The logo consists of a teal-colored abstract symbol on the left, resembling a stylized person within a circle. To the right of the symbol, the word "TRUEMED" is written in a bold, dark gray font. Below "TRUEMED", the word "GROUP" is written in a smaller, teal font, with a horizontal line extending from the right side of the word.

# Premarket Notification 510(k) Summary

| 1. | Submitter's Name: | Truemed Group LLC |
|-----|-----------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2. | Contact Person: | Jorge Trujillo Zavala<br>2002 Timberloch Place Suite 200<br>The Woodlands, TX 77380<br>Telephone: [phone] |
| 3. | Date Prepared: | April 21, 2016 |
| 4. | Device Name: | Arzzt 3.5 / 4.5 Small & Large Fragments System |
| 5. | Common Name: | Osteosynthesis plates and screws |
| 6. | Classification Name: | • Plate, Fixation, Bone and accessories per 21 CFR<br>section 888.3030<br>• Screw, Fixation, Bone and accessories per 21 CFR section<br>888.3040 |
| 7. | Product Codes: | HRS, HWC |
| 8. | Devices Classification: | Class II |
| 9. | Regulation Numbers: | 21 CFR 888.3030 21 CFR 888.3040 |
| 10. | Predicate Device (Primary): | - Synthes (USA) 3.5 mm and 4.5 mm Locking Compression<br>Plate (LCP) System with Expanded Indications K082807 |
| 11. | Device Description: | The Arzzt 3.5/4.5 Small & Large Fragments System consist<br>of a variety of plates designed for specific bone areas,<br>with orifices to receive either locking or non-locking<br>screws. The screws are can be total or partially threaded<br>and cannulated or not, some are self-tapping and they can<br>be with or without locking features. All plates and screws<br>may be manufactured in either stainless steel or titanium. |
| 12. | Intended Use: | The Arzzt 3.5/4.5 Small & Large Fragment System is<br>indicated for fixation of fractures, osteotomies, and non-<br>unions of the humerus, radius, ulna, femur, and tibia. |

{4}------------------------------------------------

Image /page/4/Picture/1 description: The image shows the logo for TrueMed Group. The logo consists of a teal-colored abstract symbol on the left, resembling a person with arms raised inside a circle. To the right of the symbol, the word "TRUEMED" is written in dark gray, with "GROUP" in teal below it. A horizontal line extends from the word "GROUP".

## 13. Test Performed:

We performed engineering analyses comparing the static bending and static torsional yield strengths of the Arzzt blocking plates to the predicate devices proving to be as strong as the predicate devices. For the screws, we performed engineering analyses comparing the maximum shear stress and thread of the Arzzt blocking and cortical screws to the predicate device.

### 14. Standards:

• ASTM F-983-86 Standard Practice for Permanent Marking of Orthopedic Implant Components • ASTM F543-07 Standard Specifications And Test Methods For Metallic Medical Bone Screws • ISO 5832-1:2007 Implants for surgery -- Metallic materials -- Part 1: Wrought stainless steel • ISO 5832-3:1996. Implants for surgery - Metallic materials - Part 3: Wrought titanium 6-aluminium 4vanadium allov The Arzzt Plates & Screw System met the requirements of the above standards.

15. Substantial Equivalence: The Arzzt 3.5 / 4.5 Small & Large Fragments System has an equivalent intended use, target population, anatomical sites, materials, biocompatibility, as well performance and properties as Synthes (USA) 3.5 mm and 4.5 mm Locking Compression Plate (LCP) System with Expanded Indications and other predicates devices for fixation of bone fractures.

> In considering the technological characteristics of the device compared to the predicate device, the Arzzt 3.5 / 4.5 Small & Large Fragments System has a solid design and the engineering analyses performed on the product demonstrate that the performance and properties are of Arzzt Plates & Screw System are substantially equivalent to the predicate device.